Evogene
EVGN
EVGN
35 hedge funds and large institutions have $2.73M invested in Evogene in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
0.76% more ownership
Funds ownership: 0.17% → 0.93% (+0.76%)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Holders
35
Holding in Top 10
–
Calls
–
Puts
$1K
Top Buyers
| 1 | +$1.76M | |
| 2 | +$303K | |
| 3 | +$153K | |
| 4 |
Morgan Stanley
New York
|
+$28.7K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
+$23K |
Top Sellers
| 1 | -$29.4K | |
| 2 | -$12.8K | |
| 3 | -$9.48K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
-$882 |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$293 |